November's top stories: Phase III trial of sirukumab, Lyrica fails trial

GlaxoSmithKline begins Phase III trial of sirukumab, Pfizer's neuropathic pain drug Lyrica fails Phase III trial, and Seattle begins Phase I/II trial of SGN-CD33A. Drugdevelopment-technology.com wraps up key headlines from November.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news